BusinessAccelerate Diagnostics Announces Pricing of Public Offering of Common StockBy Nasdaq OMXDec 10, 2015, 3:51 AM UTC
BusinessT2 Biosystems Announces Closing of Public Offering of Common StockBy Nasdaq OMXDec 9, 2015, 5:00 PM UTC
BusinessNemucore Medical Innovations Announces Appointment of Dr. Michael V. Seiden to Its Board of Directors and Clinical Advisory BoardBy Nasdaq OMXDec 9, 2015, 1:05 PM UTC
BusinessClinical Study Shows Assembly Biosciences' Oral Gemicel™ Technology Can Achieve Targeted Delivery to the Lower GI Tract for Microbiome and Other ApplicationsBy Nasdaq OMXDec 9, 2015, 12:00 PM UTC
BusinessOncothyreon Announces Data for ONT-380 in HER2-Positive Breast Cancer Patients With and Without Brain Metastases at the San Antonio Breast Cancer SymposiumBy Nasdaq OMXDec 8, 2015, 9:05 PM UTC
BusinessNovavax to Participate in the Guggenheim Securities 3rd Annual Boston Healthcare ConferenceBy Nasdaq OMXDec 8, 2015, 9:05 PM UTC
BusinessEdge Therapeutics to Participate in Guggenheim Securities 3rd Annual Healthcare ConferenceBy Nasdaq OMXDec 8, 2015, 2:00 PM UTC
BusinessUM Baltimore Grants Pataigin, LLC, Rights to Technology Developed for Rapid, Point-Of-Care Identification of Dangerous PathogensBy Nasdaq OMXDec 8, 2015, 1:00 PM UTC
